NALESSO, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 8.898
AS - Asia 5.976
EU - Europa 3.664
AF - Africa 1.588
SA - Sud America 1.377
OC - Oceania 147
Continente sconosciuto - Info sul continente non disponibili 91
Totale 21.741
Nazione #
US - Stati Uniti d'America 8.081
SG - Singapore 2.056
HK - Hong Kong 822
BR - Brasile 793
IT - Italia 753
CN - Cina 748
VN - Vietnam 461
DE - Germania 263
FI - Finlandia 245
PL - Polonia 229
SE - Svezia 194
IN - India 188
FR - Francia 152
GB - Regno Unito 145
RU - Federazione Russa 130
AR - Argentina 116
NL - Olanda 116
UA - Ucraina 115
TR - Turchia 93
MX - Messico 80
JP - Giappone 79
IE - Irlanda 78
AT - Austria 75
ZA - Sudafrica 75
ES - Italia 70
ID - Indonesia 70
EC - Ecuador 68
CO - Colombia 62
KR - Corea 61
GE - Georgia 60
AZ - Azerbaigian 59
VE - Venezuela 58
NP - Nepal 57
PY - Paraguay 57
TJ - Tagikistan 57
CA - Canada 56
IL - Israele 56
UZ - Uzbekistan 56
MA - Marocco 55
BE - Belgio 54
BJ - Benin 54
AE - Emirati Arabi Uniti 53
IQ - Iraq 53
PH - Filippine 53
RO - Romania 53
AO - Angola 52
CW - ???statistics.table.value.countryCode.CW??? 51
CY - Cipro 51
LA - Repubblica Popolare Democratica del Laos 51
SK - Slovacchia (Repubblica Slovacca) 51
KG - Kirghizistan 50
KZ - Kazakistan 50
PE - Perù 50
PS - Palestinian Territory 50
UG - Uganda 50
ME - Montenegro 49
NO - Norvegia 49
CG - Congo 48
DZ - Algeria 48
HR - Croazia 48
MD - Moldavia 48
MK - Macedonia 48
AM - Armenia 47
CZ - Repubblica Ceca 47
DK - Danimarca 47
EE - Estonia 47
EG - Egitto 47
IR - Iran 47
NG - Nigeria 47
PK - Pakistan 47
TT - Trinidad e Tobago 47
CL - Cile 46
HU - Ungheria 46
JO - Giordania 46
LY - Libia 46
SI - Slovenia 46
TH - Thailandia 46
UY - Uruguay 46
DJ - Gibuti 45
MZ - Mozambico 45
JM - Giamaica 44
KH - Cambogia 44
TN - Tunisia 44
BY - Bielorussia 43
HN - Honduras 43
BA - Bosnia-Erzegovina 42
BO - Bolivia 42
CH - Svizzera 42
GP - Guadalupe 42
MN - Mongolia 42
MY - Malesia 42
SA - Arabia Saudita 42
BB - Barbados 41
BD - Bangladesh 40
CR - Costa Rica 40
IS - Islanda 40
LB - Libano 40
PT - Portogallo 40
DO - Repubblica Dominicana 39
GN - Guinea 39
Totale 19.819
Città #
Fairfield 1.139
Singapore 1.044
Ashburn 928
Hong Kong 784
Chandler 606
Houston 442
Cambridge 429
Woodbridge 392
Seattle 330
Ann Arbor 317
Wilmington 296
Boardman 268
Beijing 239
Jacksonville 225
Princeton 203
Santa Clara 196
Medford 172
San Diego 155
Ho Chi Minh City 154
Bytom 151
Los Angeles 128
Des Moines 120
Padova 109
Munich 102
Helsinki 93
New York 86
Hanoi 84
Chicago 69
Milan 66
Dublin 65
Turku 65
São Paulo 64
Roxbury 60
Dong Ket 59
Baku 58
Hefei 56
Dushanbe 55
Nanjing 54
Tashkent 51
Cotonou 50
Vienna 50
Kampala 47
Guangzhou 46
Tbilisi 45
Warsaw 45
Luanda 44
Vientiane 44
Amman 43
London 43
Djibouti 42
Podgorica 42
Ulan Bator 42
Bishkek 41
Yerevan 40
Maputo 39
Montevideo 39
Willemstad 39
Bridgetown 38
Rome 38
Tokyo 38
Istanbul 37
Managua 37
Tallinn 37
Abidjan 36
Conakry 36
Panama City 36
Phnom Penh 36
Dakar 35
Nassau 35
Antananarivo 34
Dili 34
Libreville 34
Nairobi 34
Vicenza 34
Praia 33
Havana 32
Johannesburg 32
Lima 32
Lusaka 31
Orem 31
Reykjavik 31
Rio de Janeiro 31
Andorra la Vella 30
Dar es Salaam 30
Riga 30
Brazzaville 29
Buffalo 29
Kingston 29
Kinshasa 29
Skopje 29
Stockholm 29
Tel Aviv 29
Tripoli 29
Brooklyn 28
Castries 28
Council Bluffs 28
Zagreb 28
Bamako 27
Cayenne 27
Kigali 27
Totale 12.072
Nome #
Evaluating nephrocheck as a predictive tool for acute kidney injury 221
New option for the treatment of hyperbilirubinemia: in vitro direct hemoperfusion with the Lixelle S-35. 185
Ultrasound for the Clinical Management of Vascular Access Cannulation and Needle Position in Hemodialysis Patients 185
A Continuous Renal Replacement Therapy Protocol for Patients With Acute Kidney Injury in Intensive Care Unit With COVID-19 180
Dent's disease and prevalence of renal stones in dialysis patients in Northeastern Italy. 179
Pharmacokinetic analysis of antibiotic adsorption (vancomycin and teicoplanin) by the Lixelle extracorporeal unit. 179
The Relationship Between Intra-Parenchymal Renal Resistive Index Variation and Renal Functional Reserve in Healthy Subjects 174
In vitro Cytotoxicity of Bisphenol A in Monocytes Cell Line 173
The Rationale for Combining Normothermic Liver Machine Perfusion with Continuous Renal Replacement Therapy to Maintain Physiological Perfusate during Ex Vivo Organ Perfusion 173
A wearable hemofilter for continuous ambulatory ultrafiltration 172
Hypertension and Its Treatment in the Elderly 171
A new home based bioimpedance system for PD 171
A wearable artificial kidney: technical requirements and potential solutions 171
In-vitro Evaluation of proBPN Extracorporeal Removal during Hemodialysis with High Cut-Off Membrane 167
SARCOIDOSIS: HOW ITS DIAGNOSIS MIGHT REVEAL TROUBLED 166
Predicting Acute Kidney Injury in Intensive Care Unit Patients: The Role of Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein-7 Biomarkers 163
Family history may be misleading in the diagnosis of Dent's disease 162
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 162
Slow Continuous Ultrafiltration in Regional Citrate Anticoagulation Performed with a Standard Fluid Infusion Central Venous Catheter in Intensive Care Unit for Fluid Overload in Acute on Chronic Heart Failure: A Case Report 158
An innovative technology for safe needle disconnection after hemodialysis 156
Conservative Management in End-Stage Kidney Disease between the Dialysis Myth and Neglected Evidence-Based Medicine 155
Glucose-Free Solutions Mediated Inhibition of Oxidative Stress and Oxidative Stress-Related Damages in Peritoneal Dialysis: A Promising Solution 153
The patient safety in extracorporeal blood purification treatments of critical patients 152
Regional citrate anticoagulation high-cut-off continuous veno-venous hemodialysis for COVID-19 and AKI patients in intensive care unit 152
Rare genetic tubulopathies Gitelman's and Bartter's syndromes and their naturally occurring protection from COVID-19. 152
[Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries] 150
NGAL: a biomarker of acute kidney injury and other systemic conditions 149
Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: A systematic review 147
Extracorporeal CO(2) Removal - A Way to Achieve Ultraprotective Mechanical Ventilation and Lung Support: The Missing Piece of Multiple Organ Support Therapy 145
Oxidative stress and 'monocyte reprogramming' after kidney transplant: A longitudinal study 144
Long-term outcome of COVID-19 patients with acute kidney injury requiring kidney replacement therapy 144
Impact of different hemodiafiltration solutions on ionemia in long-term CRRT 143
Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach 143
In-vitro Evaluation of NGAL Extracorporeal Removal during Hemodialysis with High Cut-Off Membrane 142
Pulse high-volume hemofiltration in critically ill patients: A new approach for patients with septic shock 142
Definitions and Conceptualization of Dose in Continuous Renal Replacement Therapy 141
The role of advanced oxidation protein products in intensive care unit patients with acute kidney injury 141
Intra-parenchymal renal resistive index variation (IRRIV) describes renal functional reserve (RFR): Pilot study in healthy volunteers 140
The use of extracorporeal blood purification therapies and sequential extracorporeal support in patients with septic shock (EROICASS): a study protocol for a national, non-interventional, observational multicenter, prospective study 140
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review 139
Colecistectomia in dialisi peritoneale 139
FOCAL SEGMENTAL GLOMERULOSCLEROSIS RECURRENCE IN RENAL TRANSPLANTED PATIENTS OF PADOVA NEPHROLOGY, DIALYSIS AND TRANSPLANT UNIT 139
Plasma Adsorption-Perfusion (PAP). Esperienza clinica in pazienti con e senza insufficienza renale 138
Integration of blood volume, blood pressure, heart rate and bioimpedance monitoring for the achievement of optimal dry body weight during chronic hemodialysis 138
Albumin dialysis and plasma filtration adsorption dialysis system 133
Fragmented QRS in dialysis patients: too simple to be truly useful or a potential prognostic and diagnostic tool? 132
Aspergillus fumigatus peritonitis in ambulatori peritoneal dialisys: a case report and notes on the therapeutical approach 129
North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): Targeting the problem with the RIFLE criteria 128
Regional citrate anticoagulation dose for continuous renal replacement therapy. 128
Preventing infectious diseases in Intensive Care Unit by medical devices remote control: Lessons from COVID-19 128
Human parietal epithelial cells as Trojan horses in albumin overload 127
Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes 127
PLASMA ADSORPTION PERFUSION (PAP): ESPERIENZA CLINICA CLINICA IN PAZIENTI CON E SENZA INSUFFICIENZA RENALE 126
Prospective, randomized, multicenter, controlled trial (TRIATHRON 1) on a new antithrombogenic hydrophilic dialysis membrane 126
Computational modeling of effects of mechanical shaking on hemodynamics in hollow fibers 124
The Dialyzer Identification Code (DIC): A filter characteristics codification for dialyzer choice in renal replacement therapy 122
A PERSPECTIVE BIOMULECULAR APPROACH IN THE CONTROL OF THE PROGRESSION OF CHRONIC RENAL FAILURE 121
Normothermic perfusion of a human tumoral liver for 17 days with concomitant extracorporeal blood purification therapy: Case description 120
Ultrasonographic Intraparenchymal Renal Resistive Index Variation for Assessing Renal Functional Reserve in Patients Scheduled for Cardiac Surgery: A Pilot Study 119
Body Composition and Heart Rate Variability to Achieve Dry Weight and Tolerance 119
HLA-DR expression and apoptosis: A cross-sectional controlled study in hemodialysis and peritoneal dialysis patients 119
Evaluation of a New Polysulfone Hemofilter for Continuous Renal Replacement Therapy 119
[Epidemiological and molecular study of autosomal dominant polycystic kidney disease (ADPKD) in the province of Vicenza, Italy: possible founder effect?]. 116
Removal of neutrophil gelatinase-associated lipocalin by extracorporeal therapies 116
Technical Aspects of Extracorporeal Ultrafiltration: Mechanisms, Monitoring and Dedicated Technology 116
Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: An Italian multicenter study 115
Rho kinase activity and atrial fibrillation: insights fromchronic kidney disease and dialysis patients. 110
Effectiveness of sodium hypochlorite in the prevention of catheter related infections 110
C'è necessità  di un secondo insulto tubulare nella litogenesi renale? 109
The Supporting Role of Combined and Sequential Extracorporeal Blood Purification Therapies in COVID-19 Patients in Intensive Care Unit. 108
Successful use of sodium hypochlorite pack plus systemic and local antibiotic therapy for the treatment of pseudomonas infection of peritoneal dialysis catheter exit-site 108
The Vicenza "short" peritoneal catheter: A twenty year experience 108
RUOLO DELLE BIOPSIE DI PROTOCOLLO NELL'INDIVIDUAZIONE DEI MECCANISMI PRECOCI DI CAN: STUDIO DI ESPRESSIONE GENICA E GENOTIPIZZAZIONE DONATORE-RICEVENTE 108
Clinical Scenarios in Acute Kidney Injury: Pre-Renal Acute Kidney Injury 108
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments? 107
Markers of uremia and SIRS in ICU critical patients with acute renal failure treated with CRRT 107
The Quality of Life in Elderly Patients in Comprehensive Conservative Management or Hemodialysis: A Case-Control Study in Analogous Basal Conditions 106
Expression of profibrotic and antifibrotic factors in human mesangial cells in primary culture:serum-dependent stimulation by angiotensin2 andb inhibition by calcium antagonists. 105
Antioxidant Dialytic Approach with Vitamin E-Coated Membranes 105
Clinical Scenarios in Acute Kidney Injury: Hepatorenal Syndrome 105
Tolvaptan Treatment and Long-Term Impact on Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients: A Pilot Study 104
Extracorporeal Endotoxin Removal in Sepsis 104
In vitro use of standard fluid infusion central venous catheter for Slow Continuous Ultrafiltration feasibility assessment. 104
The Role of Daily Dialysate Calcium Exposure in Phosphaturic Hormones in Dialysis Patients 103
The "Ronco" catheter for continuous flow peritoneal dialysis 102
Standardized Protocol for Hemodialysis Vascular Access Assessment: The Role of Ultrasound and ColorDoppler 101
Extracorporeal Endotoxin Removal in Sepsis 101
Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies. 100
Tobramycin kinetics removal on renal replacement therapy by carpediem machine in vitro model 100
La malattia di Dent nell'uremia e prevalenza della calcolosi renale nei dializzati: lo studio veneto 99
Peritoneal Catheters Malposition/Dysfunction and Their Approach with Catheterography and Radiologic Manipulation in Peritoneal Dialysis: A Minireview and Case Series 96
Routine adoption of TIMP2 and IGFBP7 biomarkers in cardiac surgery for early identification of acute kidney injury 96
Vitamin D intoxication induced severe hypercalcemia from self-medication for COVID-19 infection: a public health problem? 95
Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Operation 95
Recombinant Varicella Zoster vaccine in haemodialysis facilities: adherence and safety 94
C’E’ NECESSITA’ DI UN SECONDO INSULTO TUBULARE NELLA LITOGENESI RENALE ? IL POSSIBILE RUOLO DELLE NEFROTOSSINE INDUSTRIALI E DELL’APOPTOSI RENALE 93
Glycopeptides pharmacokinetic comparison during direct hemoperfusion by Lixelle absorption column 93
Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry 93
Reply to: “No need for complex blood purification systems for renal replacement therapy during long-term liver normothermic machine perfusion” and “The importance of developing viability criteria to assess liver grafts undergoing multi-week normothermic perfusion” 92
UTILIZZO DEL PLASMA ADSORBIMENTO NELLA IPERBILIRUBINEMIA POST TRAPIANTO DI FEGATO 92
Totale 13.107
Categoria #
all - tutte 69.345
article - articoli 55.797
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 1.759
patent - brevetti 2.041
selected - selezionate 0
volume - volumi 2.842
Totale 131.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.297 0 0 0 0 0 44 22 53 118 56 110 894
2021/20221.853 87 238 33 154 162 224 51 93 93 141 64 513
2022/20231.310 327 114 24 135 241 132 4 87 151 13 58 24
2023/2024953 28 91 88 70 43 79 82 65 59 70 123 155
2024/20253.910 25 226 165 108 467 90 227 345 325 176 667 1.089
2025/202610.395 881 1.507 2.753 3.128 1.608 518 0 0 0 0 0 0
Totale 22.049